Mylan Could Get Out Of EpiPen Price Backlash With A Little Contrition, Analyst Says

Mylan CEO Heather Bresch may have done her company little favors by arguing it couldn't reduce EpiPen's price, with one analyst telling the firm it needs to get a little contrition and acknowledge its decision to raise the medicine's cost.